Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-19

Clinical Trial Update: Nimodipine in Vestibular Schwanommas [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for nimodipine in vestibular schwannoma is reported with unclear status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nimodipine (Nimodipine)

Snippet

Sponsor: Medical University of Vienna | Conditions: Vestibular Schwannoma | Phase 2 | Status: UNKNOWN